Michaelson Diagnostics

Smith & Nephew joins a $3.8 million Series B round for Michelson Diagnostics and its VivoSight OCT-based skin cancer detection device.
Mass Device
Mon, 02/16/15 - 11:59 am
devices
Smith & Nephew
Michaelson Diagnostics
diagnostics
skin cancer